Important point: Entacapone is not effective alone
Shortly after she started getting semiglutide injections for weight loss last year, the 54-year-old from Charlotte, N.C., went to trivia night at a local bar and indulged in chicken wings, pizza and fried jalapeno poppers only to end up vomiting
Clinical scenarios warranting consideration of GLP-1 therapy include: Type 2 diabetes management : Per ADA 2024 Standards of Care, GLP-1 RAs may be considered as initial therapy in patients with established atherosclerotic cardiovascular disease (ASCVD), high ASCVD risk, chronic kidney disease (CKD), or heart failure, or as add-on therapy when glycemic targets aren't met Established cardiovascular disease : Several GLP-1 receptor agonists have demonstrated cardiovascular risk reduction in patients with type 2 diabetes and established ASCVD Chronic kidney disease : While SGLT2 inhibitors are generally prioritized for CKD with type 2 diabetes when eGFR allows, GLP-1 RAs may provide complementary benefits Obesity with complications : When lifestyle interventions produce insufficient weight loss in patients with obesity-related comorbidities Important safety considerations include: Contraindications : Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
Trnh thuc ni c nh nng trc tip chiu vo hoc ni c m cao
PlexusDx clinical teams can tailor dose timing and escalation based on individual tolerance reports
